from May 16th dilution:
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) (Cyclacel or the Company), today announced the pricing of the underwritten offering of 6,666,667 shares of its common stock at a price to the public of $3.00 per share.
and if you wonder why she says $10:
This offering is expected to close on May 21, 2013, subject to customary closing conditions.
JMP Securities LLC is acting as the sole book-running manager and Janney Montgomery Scott LLC is acting as co-manager for this offering.
I'm thinking of buying and doing my DD. Getting out of ASTX after 4 years since the buyout. need to do something with the money. is it really worth $10?
i sold 30% of holdings. looks like the buyer may be paying over $8.50 / share on the open market to gain 50% of outstanding. I'll hold for now. worst I could do is $8.50. If the deal falls through we go & stay up in the $9's. (just like bucket said - not)
Otsuka is behind Abilify, they are making tons of $$ of depressed people. they can pay more or someone else will. haven't seen this type of opposition to a buyout in a long while